November 25, 2018 — Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read mammography as well as non-mammography studies. By using the same workstation, a compatible picture archiving and communication system (PACS) user interface and optimizing human performance engineering, radiologists become more efficient, according to Novarad.
With mammography, time is a critical commodity. Reader fatigue, reduced efficiency, and delays in diagnosing breast disease and other abnormalities visible on medical images can slow workflow between breast and non-breast studies, minimize radiologist productivity and delay patient notifications. The result can be less efficient radiologists and imaging centers, and a weaker bottom line at hospitals, imaging centers, women’s health clinics and other health facilities
“When we’re reading, sometimes we want to see previous reports, and if you want to do that in a different software you have to go over to the PACS and pull up the case, and open it there and go back and forth, which slows me down,” said Lisa Watanabe, M.D., chief medical officer of CureMetrix and associate professor in clinical radiology at the University of Southern California (USC) School of Medicine. “Being able to have everything integrated with NovaMG-Pro is really advantageous. It definitely makes me more efficient.”
NovaMG-Pro offers one-click workflow and is fully integrated with dictation/voice recognition, eliminating the need for transcription. It tracks and reports all breast-related procedures, including mammography, magnetic resonance imaging (MRI) and ultrasound. Ultimately, NovaMG-Pro streamlines workflow to significantly reduce process time, accelerate productivity and increase efficiency. The result is reduced costs, higher throughput and maximized revenue.
Those interested in learning more about the NovaMG-Pro solution may visit the company at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.
For more information: www.novarad.net
October 24, 2025 
